Cantor Fitzgerald issued their FY2025 earnings estimates for shares of Soleno Therapeutics in a report released on Tuesday, January 21st. Cantor Fitzgerald analyst K. Kluska expects that the company ...

Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) have received a consensus recommendation of “Buy” from the seven research firms that are covering the company, MarketBeat.com ...

Two Nebraska researchers have launched a startup company aimed at bringing to market an innovative method for delivering therapeutics, gene editing tools, plasmids and more to targeted locations in ...

Anish Bhatnagar, the Chief Executive Officer of Soleno Therapeutics Inc. (NASDAQ:SLNO), recently sold a significant portion of the company's stock. According to an SEC filing, Bhatnagar sold a total ...

Omega Therapeutics ( (OMGA)) has shared an announcement. Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

REDWOOD CITY, Calif., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of ...